# Missouri Sets Sights on Establishing Licensed Cannabis Research > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/state-licensed-cannabis-research-frameworks-missouri/ > **Published:** 2026-04-16T22:01:51-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:20:11-04:00 > **Clinical Summary:** Explore how state-licensed cannabis research frameworks in Missouri could advance clinical evidence beyond federal limits. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic ResearchPolicyEvidence-Based MedicineClinical StudiesState Regulation Why This Matters State-licensed [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) frameworks could accelerate clinical evidence generation outside federal constraints. This matters because clinicians currently operate with limited high-quality data on dosing, drug interactions, and patient-specific responses. Clinical Summary Missouri is developing infrastructure for licensed [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/), potentially joining states that have created pathways for clinical studies independent of federal scheduling restrictions. Such frameworks typically allow academic institutions and licensed entities to conduct controlled studies on [medical cannabis products](https://cedclinic.com/cannabis-infused-products-skin-diy-topical-recipes/) available to patients. The clinical significance depends on study design quality and whether research addresses current evidence gaps in dosing protocols, safety profiles, and therapeutic mechanisms. Dr. Caplan’s Take “I’ve been waiting for states to build these research bridges — we need data on the products patients are actually using, not just isolated compounds in federal studies. Missouri could generate the real-world evidence that helps us move from educated guessing to evidence-based [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/).” Clinical Perspective 🧠 Clinicians should monitor whether such research produces peer-reviewed data on commercially available cannabis products, standardized dosing protocols, and drug interaction profiles. The quality and clinical relevance of resulting studies will determine whether this advances evidence-based practice or simply adds to the noise. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Missouri%20sets%20sights%20on%20establishing%20licensed%20cannabis%20research%20%7C%20News%20%7C%20missour...%20%40drcaplan&url=https%3A//www.missourian.com/news/missouri-sets-sights-on-establishing-licensed-cannabis-research/article_9d61c256-47be-40d9-8c8a-2e8b3736e38d.html)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.missourian.com/news/missouri-sets-sights-on-establishing-licensed-cannabis-research/article_9d61c256-47be-40d9-8c8a-2e8b3736e38d.html)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Missouri%20sets%20sights%20on%20establishing%20licensed%20cannabis%20research%20%7C%20News%20%7C%20missour...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.missourian.com/news/missouri-sets-sights-on-establishing-licensed-cannabis-research/article_9d61c256-47be-40d9-8c8a-2e8b3736e38d.html)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.missourian.com/news/missouri-sets-sights-on-establishing-licensed-cannabis-research/article_9d61c256-47be-40d9-8c8a-2e8b3736e38d.html](https://www.missourian.com/news/missouri-sets-sights-on-establishing-licensed-cannabis-research/article_9d61c256-47be-40d9-8c8a-2e8b3736e38d.html) Table of Contents - [FAQ](#FAQ)[What is the CED Clinical Relevance rating system?](#What_is_the_CED_Clinical_Relevance_rating_system) - [What type of content does this article cover?](#What_type_of_content_does_this_article_cover) - [What does “Notable Clinical Interest” mean?](#What_does_8220Notable_Clinical_Interest8221_mean) - [Is this article about established medical facts or emerging research?](#Is_this_article_about_established_medical_facts_or_emerging_research) - [What categories of cannabis research does this cover?](#What_categories_of_cannabis_research_does_this_cover) - [Related](#Related) ## FAQ #### What is the CED Clinical Relevance rating system? The CED Clinical Relevance system appears to be a numerical rating that categorizes medical findings by their clinical importance. Rating #70 indicates “Notable Clinical Interest” for emerging findings or policy developments that warrant close monitoring. #### What type of content does this article cover? This article focuses on cannabis-related medical news from CED Clinic. It covers research findings, policy developments, evidence-based medicine, and clinical studies related to cannabis use in healthcare. #### What does “Notable Clinical Interest” mean? “Notable Clinical Interest” refers to emerging medical findings or policy developments that are worth monitoring closely by healthcare professionals. These developments may have potential implications for clinical practice but require further observation. #### Is this article about established medical facts or emerging research? This article covers emerging findings and policy developments rather than established medical facts. The “Notable Clinical Interest” classification suggests these are developing areas that need continued monitoring and evaluation. #### What categories of cannabis research does this cover? The article encompasses multiple aspects of cannabis in medicine including basic research, policy changes, evidence-based medical applications, and [clinical trial results](https://cedclinic.com/cannabidiol-liver-enzyme-elevation-healthy-adults/). This comprehensive approach provides a well-rounded view of current cannabis-related medical developments. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Missouri sets sights on establishing licensed cannabis research • Missouri Independent – Reddit](https://cedclinic.com/state-licensed-cannabis-research-programs-missouri/) A detailed look at Missouri's plans to establish licensed cannabis research and its potential impact on clinical studies and policy. [Read More](https://cedclinic.com/state-licensed-cannabis-research-programs-missouri/) [New Congressional Bill Would Let State Agencies Provide Marijuana For Research, Backed …](https://cedclinic.com/new-congressional-bill-marijuana-research-access/) Insights into federal legislative efforts supporting state-level cannabis research and access to marijuana for clinical studies. [Learn More](https://cedclinic.com/new-congressional-bill-marijuana-research-access/) [Missouri sets sights on establishing licensed cannabis research – MMJDaily](https://cedclinic.com/state-licensed-cannabis-research-missouri-initiative/) Coverage of Missouri's initiative to create licensed cannabis research pathways and the implications for [medical cannabis evidence](https://cedclinic.com/cannabis-microdosing-pain-relief-clinical-evidence/). [Explore Article](https://cedclinic.com/state-licensed-cannabis-research-missouri-initiative/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).